Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf
Background<p>Psoriasis is a long-term, immune-mediated inflammatory disorder of the skin, affecting about 2-3% of the global population with rising prevalence rates. Clinical practice has demonstrated that Fuzhenghefuzhiyang formula (FZHFZY), a topical medication applied Chinese herbal formula...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , , , , , |
| Julkaistu: |
2025
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
| _version_ | 1849927624451686400 |
|---|---|
| author | Bin Tang (56654) |
| author2 | Chen Zhang (66790) Yujie Yang (2327590) Haixin Zhong (18240646) Kexin Yang (9733218) Hao Deng (409186) Jingjie Yu (3549059) Yonggen Chen (17964038) Xiangliang Deng (8499348) Chuanjian Lu (534232) Haiming Chen (355433) |
| author2_role | author author author author author author author author author author |
| author_facet | Bin Tang (56654) Chen Zhang (66790) Yujie Yang (2327590) Haixin Zhong (18240646) Kexin Yang (9733218) Hao Deng (409186) Jingjie Yu (3549059) Yonggen Chen (17964038) Xiangliang Deng (8499348) Chuanjian Lu (534232) Haiming Chen (355433) |
| author_role | author |
| dc.creator.none.fl_str_mv | Bin Tang (56654) Chen Zhang (66790) Yujie Yang (2327590) Haixin Zhong (18240646) Kexin Yang (9733218) Hao Deng (409186) Jingjie Yu (3549059) Yonggen Chen (17964038) Xiangliang Deng (8499348) Chuanjian Lu (534232) Haiming Chen (355433) |
| dc.date.none.fl_str_mv | 2025-11-26T05:14:50Z |
| dc.identifier.none.fl_str_mv | 10.3389/fimmu.2025.1690070.s001 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/presentation/Presentation_1_Exploring_therapeutic_mechanism_of_Fuzhenghefuzhiyang_Formula_in_psoriasis_inflammation_and_metabolism_regulation_pdf/30717611 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Genetic Immunology psoriasis FZHFZY transcriptomics metabolomics integrated analysis NLRP3 |
| dc.title.none.fl_str_mv | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf |
| dc.type.none.fl_str_mv | Text Presentation info:eu-repo/semantics/publishedVersion text |
| description | Background<p>Psoriasis is a long-term, immune-mediated inflammatory disorder of the skin, affecting about 2-3% of the global population with rising prevalence rates. Clinical practice has demonstrated that Fuzhenghefuzhiyang formula (FZHFZY), a topical medication applied Chinese herbal formula developed by Prof. Lu Chuanjian, exhibits significant efficacy in alleviating psoriasis symptoms. Nevertheless, its mechanism of anti-psoriasis remains unclear.</p>Purpose<p>The purpose of this study is to decode the molecular mechanisms by which FZHFZY produces its therapeutic effects on psoriasis using an integrated multi-omics approach.</p>Methods<p>Employing both cell-based and animal studies, we systematically elucidate the pharmacodynamic substance basis and biological pathways underlying its anti-psoriasis effects by integrating network pharmacology to predict the active ingredient-target network, metabolomics to analyze endogenous metabolite changes, and transcriptome sequencing to dissect gene expression regulation.</p>Results<p>FZHFZY effectively alleviated symptoms of skin thickening, erythema, and scaling in psoriatic model mice. Network pharmacology predicted that its therapeutic effect might be related to target pathways associated with inflammation, metabolism, proliferation, pyroptosis. RNA sequencing analysis of skin lesion tissues revealed that FZHFZY modulated the inflammation-related NOD-like receptor (NLR) and IL-17 signaling pathways. Further validation by RT-PCR showed that FZHFZY markedly downregulated the mRNA levels of IL-17 and NLRP3. Metabolomics analysis of the lesion tissues identified 169 differential metabolites, and FZHFZY was found to regulate the catabolism of carbohydrates, purines, and most amino acids. Cross-analysis of the two omics approaches indicated that purine metabolism and ether lipid metabolism were associated with key genes in the NLR signaling pathway identified by MCODE analysis.</p>Conclusions<p>This study revealed that FZHFZY can effectively improve lesion conditions in a psoriasis-like mouse model, and its mechanism of action may be related to the association between purine metabolism, lipid metabolism, and key genes in the NLR signaling pathway.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_1d711af89b2247406e98fb1e1d775fa0 |
| identifier_str_mv | 10.3389/fimmu.2025.1690070.s001 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30717611 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdfBin Tang (56654)Chen Zhang (66790)Yujie Yang (2327590)Haixin Zhong (18240646)Kexin Yang (9733218)Hao Deng (409186)Jingjie Yu (3549059)Yonggen Chen (17964038)Xiangliang Deng (8499348)Chuanjian Lu (534232)Haiming Chen (355433)Genetic ImmunologypsoriasisFZHFZYtranscriptomicsmetabolomicsintegrated analysisNLRP3Background<p>Psoriasis is a long-term, immune-mediated inflammatory disorder of the skin, affecting about 2-3% of the global population with rising prevalence rates. Clinical practice has demonstrated that Fuzhenghefuzhiyang formula (FZHFZY), a topical medication applied Chinese herbal formula developed by Prof. Lu Chuanjian, exhibits significant efficacy in alleviating psoriasis symptoms. Nevertheless, its mechanism of anti-psoriasis remains unclear.</p>Purpose<p>The purpose of this study is to decode the molecular mechanisms by which FZHFZY produces its therapeutic effects on psoriasis using an integrated multi-omics approach.</p>Methods<p>Employing both cell-based and animal studies, we systematically elucidate the pharmacodynamic substance basis and biological pathways underlying its anti-psoriasis effects by integrating network pharmacology to predict the active ingredient-target network, metabolomics to analyze endogenous metabolite changes, and transcriptome sequencing to dissect gene expression regulation.</p>Results<p>FZHFZY effectively alleviated symptoms of skin thickening, erythema, and scaling in psoriatic model mice. Network pharmacology predicted that its therapeutic effect might be related to target pathways associated with inflammation, metabolism, proliferation, pyroptosis. RNA sequencing analysis of skin lesion tissues revealed that FZHFZY modulated the inflammation-related NOD-like receptor (NLR) and IL-17 signaling pathways. Further validation by RT-PCR showed that FZHFZY markedly downregulated the mRNA levels of IL-17 and NLRP3. Metabolomics analysis of the lesion tissues identified 169 differential metabolites, and FZHFZY was found to regulate the catabolism of carbohydrates, purines, and most amino acids. Cross-analysis of the two omics approaches indicated that purine metabolism and ether lipid metabolism were associated with key genes in the NLR signaling pathway identified by MCODE analysis.</p>Conclusions<p>This study revealed that FZHFZY can effectively improve lesion conditions in a psoriasis-like mouse model, and its mechanism of action may be related to the association between purine metabolism, lipid metabolism, and key genes in the NLR signaling pathway.</p>2025-11-26T05:14:50ZTextPresentationinfo:eu-repo/semantics/publishedVersiontext10.3389/fimmu.2025.1690070.s001https://figshare.com/articles/presentation/Presentation_1_Exploring_therapeutic_mechanism_of_Fuzhenghefuzhiyang_Formula_in_psoriasis_inflammation_and_metabolism_regulation_pdf/30717611CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/307176112025-11-26T05:14:50Z |
| spellingShingle | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf Bin Tang (56654) Genetic Immunology psoriasis FZHFZY transcriptomics metabolomics integrated analysis NLRP3 |
| status_str | publishedVersion |
| title | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf |
| title_full | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf |
| title_fullStr | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf |
| title_full_unstemmed | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf |
| title_short | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf |
| title_sort | Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf |
| topic | Genetic Immunology psoriasis FZHFZY transcriptomics metabolomics integrated analysis NLRP3 |